Senescence caused by telomerase inactivation in myeloid, mesenchymal, and endothelial cells has distinct effects on cancer progression
Aging · 2025
DOI: 10.18632/aging.206268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2025. Verfasst von Joseph Rupert und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, McGovern Medical School, The University of Texas Health Sc…. Hauptthemen laut MEDLINE: Telomerase, Endothelial Cells, Cellular Senescence, Myeloid Cells. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, McGovern Medical School, The University of Texas Health Sciences Center at Houston, Houston, TX 77030, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Rupert, J., Gao, Z., Yu, Y., & Kolonin, M. G. (2025). Senescence caused by telomerase inactivation in myeloid, mesenchymal, and endothelial cells has distinct effects on cancer progression. Aging. https://doi.org/10.18632/aging.206268
Vancouver
Rupert J, Gao Z, Yu Y, Kolonin MG. Senescence caused by telomerase inactivation in myeloid, mesenchymal, and endothelial cells has distinct effects on cancer progression. Aging. 2025. doi:10.18632/aging.206268
BibTeX
@article{Rupert2025,
author = {Rupert, Joseph and Gao, Zhanguo and Yu, Yongmei and Kolonin, Mikhail G},
title = {Senescence caused by telomerase inactivation in myeloid, mesenchymal, and endothelial cells has distinct effects on cancer progression},
journal = {Aging},
year = {2025},
doi = {10.18632/aging.206268}
}
EUVIMED